Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy - Wikidata - awgldk - TriplyDB

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy

http://www.wikidata.org/entity/Q35124651

about

Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial Immunotherapy for TB.

P2860

Q33793948-A40F1FB1-116F-4359-A962-31518453FCAD Q38025666-1FF84A83-FE4D-4689-9E8B-E51A6890C955

P2860

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy

http://www.wikidata.org/entity/Q35124651

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy

@ast

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy

@en

type

label

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy

@ast

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy

@en

prefLabel

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy

@ast

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy

@en

P1433

Q35124651-9E2D817C-6D80-4CCE-8BFA-0F22F084898B

P1476

Q35124651-334C00E9-5AC7-4987-86D0-1E7634CB899D

P2093

Q35124651-19F3117D-90A1-4AEE-8BFC-FB34837D4040

Q35124651-3AEA5549-EE9B-4DFF-87C0-EB82244A0DB1

Q35124651-BCCADA9C-9687-41CA-8958-B0D9F6C46802

P2860

Q35124651-01B6659B-FAEB-45D4-9460-C6A4D9536C9C

Q35124651-0DAB9913-FF4E-4BC4-8868-6A8B0685363C

Q35124651-12DF0406-31BF-4AF9-A9E6-BD0B2A586052

Q35124651-1491E2E8-1783-49E0-B309-0F48634B571B

Q35124651-15016994-6373-4659-A29C-CA7078B735F1

Q35124651-32B20BFB-05D8-4EA2-BFF1-5369850E318A

Q35124651-3B767D83-B729-4B81-B3EC-A3A845D5C017

Q35124651-46D3552E-C459-4737-AB3C-B08554437C50

Q35124651-4ACB0B64-3B9B-4F80-9805-E7605EBA29A4

Q35124651-4FF1327A-E084-45A4-8210-657FE7ECA0AF

P2888

Q35124651-747A6419-8E2C-4BD9-BFA1-71062BF959A5

P304

Q35124651-C4AA0491-A1D9-403D-AB2D-D2714D93F92A

P31

Q35124651-A5F40571-AC74-4D89-BBB9-922A749F49CD

P356

Q35124651-EBE95D41-F7F8-4671-91E4-6076DE25CF27

P478

Q35124651-09E914A5-DA1D-4DB0-A639-2221176FD3BB

P577

Q35124651-53BC923F-AA79-43D0-8A3F-AE41066D16A9

P5875

Q35124651-65F1C09E-4CBA-4EF8-BBCE-95BA02BC491E

P6179

Q35124651-FAEBCE8F-90FC-4E4D-A1A2-BFD9608B5AB0

P698

Q35124651-CFBF27AB-EFBE-47DE-9A0A-ED4A44A98A0C

P921

Q35124651-4AE6DE45-D43F-485E-8193-D5F66C78BF07

Q35124651-EA73AD88-EF3E-4320-BE04-E328E71E4EF2

P932

Q35124651-36BACEC1-C580-4150-8948-6D0E767967EB

P356

P1433

Journal of immune based therapies and vaccines

P1476

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy

@en

P2093

Gopal K Khuller

http://www.w3.org/2001/XMLSchema#string

Indu Verma

http://www.w3.org/2001/XMLSchema#string

Javaid A Sheikh

http://www.w3.org/2001/XMLSchema#string

P2860

An antimicrobial activity of cytolytic T cells mediated by granulysin

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice.

Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis.

Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode.

DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge.

Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.

Tuberculosis vaccine development: recent progress.

Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.

Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis.

P2888

P304

4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-8518-9-4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51247743

http://www.w3.org/2001/XMLSchema#string

P6179

1050485506

http://www.w3.org/2001/XMLSchema#string

P698

21703025

http://www.w3.org/2001/XMLSchema#string

P921

P932

3142482

http://www.w3.org/2001/XMLSchema#string